https://doi.org/10.1016/j.lungcan.2024.108040
M
Margaret Stalker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.1K
Citations
17
h-index
23
i10-index
Margaret Stalker is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Glutathione Transferases and Polymorphisms & Lung Cancer Diagnosis and Treatment. The author has an h-index of 17, co-authored 51 publications.
ORCID: 0000-0001-9493-7221Papers by this author
worksThe efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations
2024 · Lung Cancer · 10 citations
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
2024 · JTO Clinical and Research Reports · 8 citations
https://doi.org/10.1016/j.jtocrr.2024.100637
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC
2024 · Clinical Lung Cancer · 3 citations
https://doi.org/10.1016/j.cllc.2024.11.002
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator’s Consortium Registry Analysis
2024 · JTO Clinical and Research Reports · 1 citations
https://doi.org/10.1016/j.jtocrr.2024.100765
P1.08D.02 Survival after Salvage Treatment Following Durvalumab Consolidation in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
2024 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/j.jtho.2024.09.333
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat